Results 51 to 60 of about 2,537 (171)
Outpatient Parenteral Antimicrobial Therapy in Pediatric Patients
Objective: Outpatient parenteral antimicrobial therapy (OPAT) has been developed as an alternative approach to hospital stay for the effective treatment of infections requiring long-term therapy. The aim of this study is to evaluate the clinical outcomes
Hıncal Özbakır +10 more
doaj +1 more source
ABSTRACT Introduction Overweight and obesity are increasing rapidly in most countries. Underweight body mass index (BMI), though much less common, is also associated with adverse health outcomes. There is poor understanding of the implications of BMI in lymphoma patients.
Serif Sungur +14 more
wiley +1 more source
The OPAT opportunity for beta-lactam individualization
Abstract Beta-lactam therapeutic drug monitoring has been growing in prevalence in the acute care hospital setting. Expansion of its use to outpatient parenteral antimicrobial therapy requires careful consideration of potential logistical and therapeutic barriers.
Lindsey M. Childs-Kean +4 more
openaire +3 more sources
X‐Ray Tomography Analysis of Damage Mechanisms in Metal Matrix Syntactic Foams During Compression
In situ synchrotron X‐ray tomography is used to investigate the internal damage mechanisms of AlSi12 metal matrix syntactic foam with ceramic hollow spheres during compressive loading. It is concluded that a homogeneous distribution of the second‐phase filler material results in a sequential collapse in a localized region; this leads to controlled and ...
Indrajeet Tambe +8 more
wiley +1 more source
Background: Outpatient parenteral antimicrobial therapy (OPAT) is a common approach to treating complex infections, offering benefits of higher patient satisfaction, reduced risk of hospital-acquired infections, and lower healthcare costs.
Manon Nitta +11 more
doaj +1 more source
In this systematic literature review and meta-analysis, we did not find a statistically significant difference in readmission and treatment failure rates between home-based and facility-based OPAT.
Shinya Hasegawa +3 more
doaj +1 more source
Breakpoints: OPAT - the final frontier, parts 1 and 2 [PDF]
Graphical Abstract.
openaire +2 more sources
ABSTRACT Background Invasive candidiasis (IC), life‐threatening fungal infections with high economic burden, are often treated first‐line with daily intravenous echinocandins. A new once weekly echinocandin, rezafungin, demonstrated statistically non‐inferior efficacy and numerically shorter intensive care unit (ICU) stay compared to caspofungin in ...
Noemi Muszbek +10 more
wiley +1 more source
It is not known whether sequential outpatient parenteral antimicrobial (OPAT) is as safe and effective as conventional hospitalization in patients with S. aureus bacteremia (SAB).
Nerea Castillo-Fernández +27 more
doaj +1 more source
ABSTRACT Background Echinocandins are the first‐line treatment for invasive candidiasis. Rezafungin is a novel echinocandin with improved pharmacokinetic properties that allow for once‐weekly intravenous administration, offering potential advantages in complex clinical settings.
Jorge Boán +10 more
wiley +1 more source

